https://www.avient.com/products/polymer-additives/uv-and-light-blocking-additives/colormatrix-lactra-esl
Aimed at shelf life ranging from 2 weeks to 3 months
https://www.avient.com/news/avient-earns-luxe-pack-green-award-sustainability-initiative
The honor was given during the LUXE PACK New York trade show last week for Avient’s ongoing efforts to reduce scope 1 & 2 greenhouse gas (GHG) emissions.
https://www.avient.com/knowledge-base/case-study/reinforcing-stronger-infrastructure?ind[]=21509
Video Polystrand Unidirectional Composite Tape
Continuous fiber reinforced thermoplastic composite tape is slit to custom widths from 2" to 24".
https://www.avient.com/news/polyone-launches-new-innovative-vibration-damping-technology
April 2, 2015
https://www.avient.com/news/polyone-inspiring-electric-vehicle-designs-lineup-trendsetting-polymer-colors
NOTE to EDITORS: EVs remain a novelty in the automotive space, accounting for less than 2% of global vehicle sales, but demand is increasing and expected to grow from slightly over 1 million vehicles in 2017 to 11 million vehicles by 2025, according to a recent report by BloombergNEF.
https://www.avient.com/sites/default/files/2021-01/w9-avient-corporation-july-2020.pdf
The number shown on this form is my correct taxpayer identification number (or I am waiting for a number to be issued to me); and 2.
You must cross out item 2 above if you have been notified by the IRS that you are currently subject to backup withholding because you have failed to report all interest and dividends on your tax return.
For real estate transactions, item 2 does not apply.
https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
Autoinjector Pen - Avient Application Study.mm (1) AUTO-INJECTOR APPLICATION STUDY M A T E R I A L T E C H N O L O G I E S + S E R V I C E S F O R N E X T G E N E R A T I O N D E S I G N S Avient Corporation 1 Avient Corporation 2 Innovating Design Medical innovations and plastics have gone hand-in-hand to make healthcare safer, cleaner, and more accessible for all.
We can help tackle your toughest challenges with our • In-depth industry knowledge • Expansive material solutions • Far-reaching technical capabilities and services Avient Corporation 4 1 Injection window Integrated rigid needle shield 2 Cap 3 1.
Requirements: Excellent clarity, scratch resistance and exceptional toughness for visualization of medicant levels Solution: Avient Distribution HC Portfolio: Acrylic, copolyester, PC 2.
https://www.avient.com/sites/default/files/2020-12/therma-tech-processing-guide.pdf
Gate type should be selected based on location and part geometry. 2.
Half-round runners are not recommended due to excessive pressure drop. 2.
Place vents at the end of fill and anywhere potential knit/weld lines will occur. 2.
https://www.avient.com/sites/default/files/2022-06/Maxxam FR Injection Molding Processing Guide.pdf
Standard grades in the portfolio conform to UL 94 V-2, V-0 and 5VA performance ratings, and many offer elevated Relative Thermal Index (RTI) ratings.
Drying non-halogenated materials is suggested. 2 hours @ 100 (38) Moisture Range (%) Not required
Follow up by purging machine with general purpose PP • Residence time should not exceed 5 minutes for Maxxam FR products • General ventilation is suggested Shut Down • Purge the equipment with a general purpose PP • All tooling and equipment must be free of any residual Maxxam FR upon shut down • Continue generating parts made from the natural PP until clear • Wipe down tool steel with mold cleaner • When using a hot runner system, care must be taken to remove residual product from the manifold MOLD DESIGN RECOMMENDATIONS Cold Slug Wells • Place cold slug wells at the base of the sprue to capture the cold material first emerging from the nozzle • Place cold slug wells at every 90° bend in the runner system • Well depths approximately 2–3 times the diameter of the runner provide best results Draft Angle • Draft angle should be 1/2°–1° per side.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520BOAML%2520Basic%2520Materials%2520Conference%2520w%2520non-GAAP%252012%252011%25202014.pdf
Slide 1 PolyOne Corporation Page 1 PolyOne Investor Presentation Bank of America Merrill Lynch 2014 US Basic Materials Conference Boston, MA December 11, 2014 PolyOne Corporation Page 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.5 million shares in Q3 2014 Repurchased 9.7 million shares since early 2013 10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?
Platform operating income mix percentage 2005Y* 2008Y* 2010Y* 2013Y Q3 2014 YTD Global Color, Additives and Inks $ 4.3 $ 28.1 $ 37.7 $ 104.0 $ 98.2 Global Specialty Engineered Materials 0.4 17.6 49.7 57.2 55.6 Designed Structures and Solutions - - - 33.4 37.2 Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 194.6 $ 191.0 Performance Products and Solutions 75.7 31.3 54.0 56.0 51.4 Distribution 19.5 28.1 42.0 63.3 53.2 Joint ventures 91.9 28.6 18.9 - - Corporate and eliminations (51.5) (425.1) (27.7) (82.4) (126.2) Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 231.5 $ 169.4 Less: Corporate operating expense 51.5 425.1 27.7 82.4 126.2 Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 313.9 $ 295.6 Specialty platform operating mix percentage 2% 34% 43% 62% 65% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.